BERLIN – October 28, 2026 -- Appian (Nasdaq: APPN) and contract research organisation PSI have taken a live AI-powered process orchestration solution for clinical trial site identification and selection into operation, the first joint project between the two companies.
The solution covers therapeutic areas, indications and geographies. It moves previously manual, decentralised steps into a single digital process, from project initiation through the later stages of site selection.